Association of cord serum albumin with neonatal hyperbilirubinemia among term-neonates
DOI:
https://doi.org/10.18203/2320-6012.ijrms20202250Keywords:
Cord serum albumin, Neonatal hyperbilirubinemia, Total serum bilirubinAbstract
Background: NH affects nearly 60% of term and 80% of preterm neonates during first week of life. 6.1% of well term newborn have a serum bilirubin over 12.9 mg%. Serum bilirubin over 15 mg% is found in 3% of normal term newborns. Neonatal Hyperbilirubinemia (NH) is a cause of concern for the parents as well as for the paediatricians. Aim of study to find out the association between various levels of cord serum albumin (CSA) and significant neonatal hyperbilirubinemia requiring interventions like phototherapy or exchange transfusion and whether it can be used as a risk indicator for subsequent development of significant jaundice.
Methods: The present study was conducted on 150 randomly selected eligible term neonates delivered at Department of Pediatrics, Rajkiya Mahila Chikitsalaya, JLN Medical College and Associated Group of Hospitals, Ajmer, India.
Results: Authors conducted a prospective study on 150sequentially born term babies. Cord blood was collected at birth and cord serum albumin estimation was done within 4-6 hours of collection of the blood. Cohort was grouped into Group 1, Group 2 and Group 3 based on CSA level ≤ 2.8g/dl, 2.9-3.3g/dl and ≥ 3.4 g/dl respectively. Knowledge of risk factors of NH in neonates could influence decision of early discharge vs. prolonged observation cord serum albumin level of ≤ 2.8g/dl has a correlation with incidence of significant hyperbilirubinemia in term newborns. So this ≤ 2.8g/dl of cord serum albumin level can be used as risk indicator to predict the development of significant hyperbilirubinemia. Whereas cord serum albumin level ≥3.4g/dl is considered safe.
Conclusions: Term neonates with hyperbilirubinemia with a total serum bilirubin level ≥17 mg/dl had levels of cord serum albumin of ≤ 2.8 g/dl, and this can be used as a risk indicator to predict the development of NH.
References
Meharban Singh. Care of the Newborn. 7th ed. New Delhi: Sagar Publications; Chapter 18, Neonatal Jaundice, 2010: 254-274.
Cloharty JP, Stork AR, Eichenwald EC, Hansen AR. Manual of neonatal care. 7th ed, Philadelphia: Lippincott Willams and Wilkins; Chapter 26, Neonatal Hyperbilirubinemia; 2012: 304-339.
Radmacher P, Massey C, Adamkin D. Hiden Morbidity With Successful Early Discharge. J Perinatol. 2002;22(1):15-20.
Kiely M, Drum MA, Kessel W. Early discharge, risks, benefits and who decides. Clin perinatol. 1998 Sep;25(3):539-53.
American Academy of Pediatrics, Clinical Practice Guideline; Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation, Pediatrics 2004;114(1):297-316
Penn AA, Enzmann DR, Hahn JS, Stevenson DK. Kernicterus in a full term infant. Pediatrics. 1994 Jun 1;93(6):1003-6.
Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics. 1995 Oct 1;96(4):730-3.
Taksande A, Vilhekar K, Jain M, Zade P, Atkari S, Verkey S. Prediction of the development of neonatal hyperbilirubinemia by increased umbilical cord blood bilirubin. Ind Medica. 2005;9(1):5-9.
Rostami N, Mehrabi Y. Identifying the newborns at risk for developing significant hyperbilirubinemia by measuring cord bilirubin levels. J Arab Neonatal Forum 2005;2:81-5.
Maisels MJ, Kring E. Length of stay, Jaundice and hospital readmission. Pediatrics.1998;101(6):995-8.
Rudy Satrya, Sjarif Hidayat Effendi, Dida Akhmad Gurnida. Correlation between cord blood bilirubin level and incidence of hyperbilirubinemia in term newborns. Paediatrica Indonesiana 2009;49(6):349-54.
Trivedi DJ, Markande DM, Vidya BU, Bhat M, Hegde PR. et al, Cord Serum bilirubin and Albumin in Neonatal Hyperbilirubinemia, Int J Int Sci Inn Tech Sec A. 2013;2(2):39-42.
Sahu S, Abraham R, John J, Mathew MA, Res M. Cord blood albumin as a predictor of neonatal jaundice. Int J Biol Med Res. 2011 Jan 31;2(1):436-8.
